0
ARTICLE |

Ranitidine Pharmacokinetics and Central Nervous System

Richard L. McIsaac, PhD; Kevin M. Koch, PhD; James H. Lewis, MD
Arch Intern Med. 1994;154(3):342-343. doi:10.1001/archinte.1994.00420030158017.
Text Size: A A A
Published online

We wish to point out several serious flaws in the design, methodology, and interpretation of the study reported by Slugg and Haug in the November 1992 issue of the Archives,1 regarding central nervous system (CNS) adverse reactions (ADRs) with ranitidine. While it is acknowledged that ranitidine is associated with rare reports of CNS adverse events (including malaise, dizziness, somnolence, insomnia, vertigo, mental confusion, agitation, depression, hallucinations, blurred vision, and involuntary motor disturbances), these are most often seen in the setting of renal or hepatic impairment among severely ill hospitalized patients, when multiple factors may be involved in their causation. Collectively, CNS-ADRs have occurred in fewer than 0.1% of patients receiving ranitidine in controlled clinical trials (data on file, Glaxo Inc, Research Triangle Park, NC).

Several aspects of the study design are likely to have introduced bias. Although prospective, the study does not attempt to test a stated hypothesis nor

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();